Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMYXR.L Regulatory News (MYXR)

  • There is currently no data for MYXR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Annual Meeting

13 Jul 2022 15:32

RNS Number : 3887S
MyCelx Technologies Corporation
13 July 2022
 

13 July 2022

 

 

MYCELX Technologies Corporation

 

("MYCELX" or the "Company") (AIM: MYX or MYXR)

 

Result of Annual Meeting

 

 

The Company is pleased to announce that, at its Annual Meeting held on 13 July 2022 at the offices of Canaccord Genuity, 88 Wood Street, London, EC2V 7QR, the resolutions set out in the Notice of Annual Meeting were duly passed on a Poll.

 

Full details of the resolutions passed are set out in the Notice of Meeting which is available on the Company's website www.mycelx.com.

 

Resolutions

For / Discretion

Against

Total

Vote withheld*

Number

%

Number

%

1A To elect Tom Lamb as a Director

 

12,269,986

 

100.00

 

-

 

-

12,269,986

-

1B To elect Connie Mixon as a Director

12,269,986

 

100.00

 

-

 

 

 

-

12,269,986

-

1C To elect Haluk (Hal) Alper as a Director

 

12,269,986

 

100.00

-

-

12,269,986

-

1D To elect Andre Schnabl as a Director

 

12,269,986

 

100.00

-

-

 

12,269,986

 

-

 

2. Ratification of appointment of Deloitte & Touche LLP as independent registered public accounting firm

 

12,269,986

 

100.00

-

-

12,269,986

-

 

*'Vote withheld' is not a vote in law and is not counted in the calculation of the proportion of the votes 'For' and 'Against' a resolution.

 

For further information please contact:

 

MYCELX Technologies Corporation

Connie Mixon, CEO

Kim Slayton, CFO

 

 

 

Tel: +1 888 306 6843

Canaccord Genuity Limited (Nomad and broker)

Henry Fitzgerald-O'Connor

Gordon Hamilton

 

Tel: +44 20 7523 8150

Celicourt

Mark Antelme

Jimmy Lea

 

Tel: +44 20 8434 2754

 

Notes to Editors

Through its revolutionary patented water technology with a mission to reduce the impact of industry on the environment, MYCELX brings its customers material benefits in terms of supporting environmental goals, performance enhancement, cost savings and small footprint. Working beyond any ordinary filtration methods, MYCELX's proprietary technology achieves oil removal to less than one part per million as well as removal of other emerging contaminants in water streams. MYCELX supports its international customers across the oil & gas value chain by ensuring clean water discharge or reuse and in groundwater remediation for industrial and military sites. MYCELX also provides advanced air filtration technology for manufacturing and industrial facilities, effectively removing oil particles and biologicals to maintain continuous and safe air quality levels.

For more information, visit www.MYCELX.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGBKNBBQBKDFOD
Date   Source Headline
26th Nov 20137:00 amRNSFast-to-market lease programme yields new leasings
30th Oct 20133:21 pmRNSDirector/PDMR Shareholding
29th Oct 20131:56 pmRNSBlocklisting Interim Review
16th Oct 20133:12 pmRNSDirector Shareholding / Warrant Exercise
3rd Oct 20137:00 amRNSInvestor Presentation
12th Sep 20137:00 amRNSHalf Year Results Statement
19th Aug 20139:06 amRNSNotice of Results
7th Aug 20139:29 amRNSBalance of respective lines of stock
10th Jun 20135:16 pmRNSChange of Main Office Address
3rd Jun 20133:19 pmRNSTotal Voting Rights
28th May 20135:02 pmRNSHolding(s) in Company
28th May 20132:54 pmRNSDirector/PDMR Shareholding
24th May 20138:52 amRNSHolding(s) in Company
14th May 20132:14 pmRNSResult of Annual Meeting
14th May 20137:00 amRNSOperational Update & Directorate Change
9th May 20137:00 amRNSExercise of Warrant
23rd Apr 201312:49 pmRNSApplication for Block Admission
19th Apr 20137:00 amRNSAnnual Financial Report/Directorate Change
15th Apr 20132:18 pmRNSHolding(s) in Company
26th Mar 20135:21 pmRNSHolding(s) in Company
13th Mar 20137:00 amRNS2012 Preliminary Results
18th Feb 201312:09 pmRNSTransfer of MyCelx Shares between lines of stock
3rd Jan 20137:00 amRNSIssue of Equity/Total Voting Rights
12th Nov 20129:52 amRNSTransfer of MyCelx Shares between lines of stock
8th Oct 20124:11 pmRNSTransfer of MyCelx Shares between lines of stock
13th Sep 20127:00 amRNSAppointment of CFO and Board Director
30th Aug 20127:00 amRNSMyCelx Shares to be Traded on CREST
14th Aug 20127:01 amRNSWebcast interview with CEO
14th Aug 20127:00 amRNSHalf Year Results
8th Aug 20127:00 amRNSContract Win for US$2.35 Million
31st May 20127:00 amRNSRe Contract
10th May 201211:02 amRNSResult of Annual Meeting/Grant of Share Option
9th May 20127:00 amRNSTrading Statement
23rd Apr 20127:00 amRNSPurchase Orders Received for US$2.65 million
17th Apr 20125:34 pmRNSAnnual Financial Report
6th Mar 20127:00 amRNS2011 Preliminary Results
27th Feb 20127:00 amRNSNotice of Preliminary Results
9th Jan 20127:00 amRNSNon-Executive Director Appointment
21st Dec 201110:10 amRNSAccident at Gainesville R&D Site
1st Nov 201112:01 pmRNSPurchase Order Update
1st Nov 20117:00 amRNSPurchase Order and Business Update
27th Sep 20117:00 amRNSHalf Year Results Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.